+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Smart Insulin Pens Global Market Report 2021: COVID-19 Growth and Change to 2030

  • ID: 5315004
  • Report
  • April 2021
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • BERLIN-CHEMIE
  • Biocorp
  • Diabnex
  • Digital Medics Pvt Ltd.
  • F. Hoffmann-La Roche AG
  • Insulet Corporation
Smart Insulin Pens Global Market Report 2021: COVID-19 Growth And Change To 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global smart insulin pens market.



This report focuses on the smart insulin pens market which is experiencing strong growth. The report gives a guide to the smart insulin pens market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:

Where is the largest and fastest growing market for the smart insulin pens? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Smart Insulin Pens market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider smart insulin pens market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The smart insulin pens market section of the report gives context. It compares the smart insulin pens market with other segments of the smart insulin pens market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, smart insulin pens indicators comparison.
Scope

Markets Covered:
1) By Type: First Generation Pens; Second Generation Pens (Bluetooth Enabled, USD Connected)
2) By End User: Hospitals & Clinics; Ambulatory Surgical Centres; Home Care Settings3) By Usability: Prefilled; Reusable
4) By Application: Type 1 Diabetes; Type 2 Diabetes

Companies Mentioned: Companion Medical; Eli Lilly and Company; Novo Nordisk A/S; Diamesco Co. Ltd.; Emperra GmbH E-Health Technologies

Countries: Brazil; China; France; Germany; India; Indonesia; Japan; South Korea; Russia; UK; USA; Australia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions; per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Frequently Asked Questions about the Global Smart Insulin Pens Market

What is the estimated value of the Global Smart Insulin Pens Market?

The Global Smart Insulin Pens Market was estimated to be valued at €0.10 billion in 2021.

What is the growth rate of the Global Smart Insulin Pens Market?

The growth rate of the Global Smart Insulin Pens Market is 7.3%, with an estimated value of €0.10 billion by 2025.

What is the forecasted size of the Global Smart Insulin Pens Market?

The Global Smart Insulin Pens Market is estimated to be worth €0.10 billion by 2025.

Who are the key companies in the Global Smart Insulin Pens Market?

Key companies in the Global Smart Insulin Pens Market include Companion Medical, Eli Lilly and Company, Novo Nordisk A/S, Diamesco Co. Ltd., Emperra GmbH E, Health Technologies, Digital Medics Pvt Ltd., F. Hoffmann and Insulet Corporation.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • BERLIN-CHEMIE
  • Biocorp
  • Diabnex
  • Digital Medics Pvt Ltd.
  • F. Hoffmann-La Roche AG
  • Insulet Corporation
1. Executive Summary

2. Smart Insulin Pens Market Characteristics

3. Smart Insulin Pens Market Trends And Strategies

4. Impact Of COVID-19 On Smart Insulin Pens

5. Smart Insulin Pens Market Size And Growth
5.1. Global Smart Insulin Pens Historic Market, 2015-2020, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Smart Insulin Pens Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Smart Insulin Pens Market Segmentation
6.1. Global Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • First Generation Pens
  • Second Generation Pens (Bluetooth Enabled, USD Connected
6.2. Global Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals & Clinics
  • Ambulatory Surgical Centres
  • Home Care Settings
6.3. Global Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Prefilled
  • Reusable
6.4. Global Smart Insulin Pens Market, Segmentation 0, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

7. Smart Insulin Pens Market Regional And Country Analysis
7.1. Global Smart Insulin Pens Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Smart Insulin Pens Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Smart Insulin Pens Market
8.1. Asia-Pacific Smart Insulin Pens Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Smart Insulin Pens Market
9.1. China Smart Insulin Pens Market Overview
9.2. China Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Smart Insulin Pens Market
10.1. India Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Smart Insulin Pens Market
11.1. Japan Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Smart Insulin Pens Market
12.1. Australia Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Smart Insulin Pens Market
13.1. Indonesia Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Smart Insulin Pens Market
14.1. South Korea Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Smart Insulin Pens Market
15.1. Western Europe Smart Insulin Pens Market Overview
15.2. Western Europe Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Smart Insulin Pens Market
16.1. UK Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Smart Insulin Pens Market
17.1. Germany Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Smart Insulin Pens Market
18.1. France Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Smart Insulin Pens Market
19.1. Eastern Europe Smart Insulin Pens Market Overview
19.2. Eastern Europe Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Smart Insulin Pens Market
20.1. Russia Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Smart Insulin Pens Market
21.1. North America Smart Insulin Pens Market Overview
21.2. North America Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Smart Insulin Pens Market
22.1. USA Smart Insulin Pens Market Overview
22.2. USA Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Smart Insulin Pens Market
23.1. South America Smart Insulin Pens Market Overview
23.2. South America Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Smart Insulin Pens Market
24.1. Brazil Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Smart Insulin Pens Market
25.1. Middle East Smart Insulin Pens Market Overview
25.2. Middle East Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Smart Insulin Pens Market
26.1. Africa Smart Insulin Pens Market Overview
26.2. Africa Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Smart Insulin Pens Market Competitive Landscape And Company Profiles
27.1. Smart Insulin Pens Market Competitive Landscape
27.2. Smart Insulin Pens Market Company Profiles
27.2.1. Companion Medical
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Eli Lilly and Company
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Novo Nordisk A/S
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Diamesco Co. Ltd.
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Emperra GmbH E-Health Technologies
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Smart Insulin Pens Market

29. Smart Insulin Pens Market Future Outlook and Potential Analysis

30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. The Publisher
30.5. Copyright And Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • BERLIN-CHEMIE
  • Biocorp
  • Diabnex
  • Digital Medics Pvt Ltd.
  • F. Hoffmann-La Roche AG
  • Insulet Corporation
Major players in the smart insulin pens market are Companion Medical, Eli Lilly and Company, Novo Nordisk A/S, Diamesco Co. Ltd., Emperra GmbH E-Health Technologies, Digital Medics Pvt Ltd., F. Hoffmann-La Roche AG, Insulet Corporation, Jiangsu Delfu medical device Co. Ltd., and Bigfoot biomedical.

The global smart insulin pens market is expected grow from $0.082 billion in 2020 to $0.086 billion in 2021 at a compound annual growth rate (CAGR) of 4.9%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $0.114 billion in 2025 at a CAGR of 7%.

The smart insulin pens market consists of sales of smart insulin pens which allows to dial the insulin dose accurately and related products. The company’s manufacturing the smart insulin pens are primarily engaged in designing and manufacturing of first- and second-generation smart insulin pens which are either reusable or pre-filled for the application of delivering accurate insulin dose in Type 1 Diabetes and Type 2 Diabetes. The revenue generated by these companies is through sales of these pens to Hospitals & Clinics, Ambulatory surgical centers and Home care settings.

The smart insulin pens market covered in this report is segmented by type into first generation pens, second generation pens (Bluetooth enabled, USB connected); by end user into hospitals & clinics, ambulatory surgical centers, home care settings; by usability into prefilled, reusable and by application into type 1 diabetes, type 2 diabetes.

The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Diabetics may be prescribed with two types of insulin for better control over blood glucose levels. They usually prefer a pre-mixed insulin (combination) or a method in which the insulin doses could be mixed and once puncture is necessary to deliver the different types of insulin doses required. Multiple punctures for the insulin delivery can lead to poor adherence of the medication which in turn results in poor glycemic control. In 2018, a study published states that poor glycemic control (A1c>7%) was reported in 68% of respondents and there was an association between A1c >7% and poor adherence levels. Dislike towards injection to a large extent and needle phobia can result in poor adherence levels. It is estimated that over 10% of population have needle phobia. These factors can reduce the adherence of smart insulin pens where two types of insulin can't be mixed and results in multiple needle punctures which thereby effect the purpose of the insulin being administered which is expected to hinder the market growth.

In February 2020, Senseonics a US-based medical technology company which primarily focuses on the design, development and commercialization of glucose monitoring products announced partnership with Companion Medical. The partnership will benefit both the companies by integrating Eversense® CGM System with the InPen™ smart system for accurate insulin delivery. Companion Medical is a US-based company which aims at achieving desirable diabetes outcomes and manufactured InPen™ which is the US first FDA approved insulin pen.

Accurate dose of insulin can be achieved than vial or a syringe with an insulin pen. For kids who need to take insulin during school time and visually impaired diabetic patients, an accurate dose of insulin can even be pre-set over the dosage dial which helps in accurate delivery of dose at the time of injection. Echo Plus by Novo Nordisk which is a pediatric friendly insulin pen allows even half-unit dosing with a maximum of 30 units. HumaPen Luxura HD from Lilly allows the delivery of insulin in half-unit increments and NovoPen Junior - Insulin Pen by Novo Nordisk can deliver highly accurate doses of insulin and finely adjusts small doses even half-unit increments. The accurate adjustments and delivery of doses of insulin can avoid either over-dosing or low-dosing of the drug which is expected to increase the demand of smart insulin pens and drive the market growth.

The next generation smart insulin pens go far beyond memory storage. They help in calculating personalized doses, track glucose continuously and connects with apps of smartphones to visualize the data. In 2019, Novo Nordisk and Abbott partnered to integrate insulin dose data into the digital health tools which aims at connecting key technologies such as continuous glucose monitoring and insulin pens thus simplifying diabetes management. The NovoPen 6 and the NovoPen Echo Plus pens will be able to connect to the Dexcom G6 CGM and the Diasend diabetes management platform (Glooko). In 2019, Companion Medical announced that the Bluetooth-enabled InPen which takes away the guesswork from dosing of insulin with an in-app bolus calculator that uses precise carbohydrate ratios and correction factors and calculates the personalized insulin doses. This enhances the ease of usage of smart insulin pens which is expected to boost the market.

The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Companion Medical
  • Eli Lilly and Company
  • Novo Nordisk A/S
  • Diamesco Co. Ltd.
  • Emperra GmbH E-Health Technologies
  • Digital Medics Pvt Ltd.
  • F. Hoffmann-La Roche AG
  • Insulet Corporation
  • Jiangsu Delfu medical device Co. Ltd.
  • Bigfoot biomedica
  • Injex UK
  • Smith’s Medical
  • NIPRO Medical Corporation
  • Biocorp
  • BERLIN-CHEMIE
  • Diabnex
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll